These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32374857)

  • 1. Identifying and Characterizing Stress Pathways of Concern for Consumer Safety in Next-Generation Risk Assessment.
    Hatherell S; Baltazar MT; Reynolds J; Carmichael PL; Dent M; Li H; Ryder S; White A; Walker P; Middleton AM
    Toxicol Sci; 2020 Jul; 176(1):11-33. PubMed ID: 32374857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation risk assessment for occupational chemical safety - A real world example with sodium-2-hydroxyethane sulfonate.
    Wood A; Breffa C; Chaine C; Cubberley R; Dent M; Eichhorn J; Fayyaz S; Grimm FA; Houghton J; Kiwamoto R; Kukic P; Lee M; Malcomber S; Martin S; Nicol B; Reynolds J; Riley G; Scott S; Smith C; Westmoreland C; Wieland W; Williams M; Wolton K; Zellmann T; Gutsell S
    Toxicology; 2024 Aug; 506():153835. PubMed ID: 38857863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Next-Generation Risk Assessment Case Study for Coumarin in Cosmetic Products.
    Baltazar MT; Cable S; Carmichael PL; Cubberley R; Cull T; Delagrange M; Dent MP; Hatherell S; Houghton J; Kukic P; Li H; Lee MY; Malcomber S; Middleton AM; Moxon TE; Nathanail AV; Nicol B; Pendlington R; Reynolds G; Reynolds J; White A; Westmoreland C
    Toxicol Sci; 2020 Jul; 176(1):236-252. PubMed ID: 32275751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are Non-animal Systemic Safety Assessments Protective? A Toolbox and Workflow.
    Middleton AM; Reynolds J; Cable S; Baltazar MT; Li H; Bevan S; Carmichael PL; Dent MP; Hatherell S; Houghton J; Kukic P; Liddell M; Malcomber S; Nicol B; Park B; Patel H; Scott S; Sparham C; Walker P; White A
    Toxicol Sci; 2022 Aug; 189(1):124-147. PubMed ID: 35822611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Early Biological Effects of Isoprene-Derived Particulate Matter Enhanced by Anthropogenic Pollutants.
    Surratt JD; Lin YH; Arashiro M; Vizuete WG; Zhang Z; Gold A; Jaspers I; Fry RC
    Res Rep Health Eff Inst; 2019 Mar; 2019(198):1-54. PubMed ID: 31872748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative and quantitative concentration-response modelling of gene co-expression networks to unlock hepatotoxic mechanisms for next generation chemical safety assessment.
    Kunnen SJ; Arnesdotter E; Willenbockel CT; Vinken M; van de Water B
    ALTEX; 2024; 41(2):213-232. PubMed ID: 38376873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.
    Paul Friedman K; Gagne M; Loo LH; Karamertzanis P; Netzeva T; Sobanski T; Franzosa JA; Richard AM; Lougee RR; Gissi A; Lee JJ; Angrish M; Dorne JL; Foster S; Raffaele K; Bahadori T; Gwinn MR; Lambert J; Whelan M; Rasenberg M; Barton-Maclaren T; Thomas RS
    Toxicol Sci; 2020 Jan; 173(1):202-225. PubMed ID: 31532525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products.
    Moxon TE; Li H; Lee MY; Piechota P; Nicol B; Pickles J; Pendlington R; Sorrell I; Baltazar MT
    Toxicol In Vitro; 2020 Mar; 63():104746. PubMed ID: 31837441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next generation risk assessment for skin allergy: Decision making using new approach methodologies.
    Gilmour N; Reynolds J; Przybylak K; Aleksic M; Aptula N; Baltazar MT; Cubberley R; Rajagopal R; Reynolds G; Spriggs S; Thorpe C; Windebank S; Maxwell G
    Regul Toxicol Pharmacol; 2022 Jun; 131():105159. PubMed ID: 35311660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.
    Jenke D; Carlson T
    PDA J Pharm Sci Technol; 2014; 68(5):407-55. PubMed ID: 25336416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision making in next generation risk assessment for skin allergy: Using historical clinical experience to benchmark risk.
    Reynolds J; Gilmour N; Baltazar MT; Reynolds G; Windebank S; Maxwell G
    Regul Toxicol Pharmacol; 2022 Oct; 134():105219. PubMed ID: 35835397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers in aquatic plants: selection and utility.
    Brain RA; Cedergreen N
    Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human health screening level risk assessments of tertiary-butyl acetate (TBAC): calculated acute and chronic reference concentration (RfC) and Hazard Quotient (HQ) values based on toxicity and exposure scenario evaluations.
    Bus JS; Banton MI; Faber WD; Kirman CR; McGregor DB; Pourreau DB
    Crit Rev Toxicol; 2015 Feb; 45(2):142-71. PubMed ID: 25629921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety assessment of personal care products/cosmetics and their ingredients.
    Nohynek GJ; Antignac E; Re T; Toutain H
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):239-59. PubMed ID: 20005888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tiered asthma hazard characterization and exposure assessment approach for evaluation of consumer product ingredients.
    Maier A; Vincent MJ; Parker A; Gadagbui BK; Jayjock M
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):903-13. PubMed ID: 26416168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.